Breast cancer screenings present an additional opportunity to identify more women who would also qualify for lung cancer screening, authors of a new paper in JAMA said.

While Black women have lower incidence of breast cancer diagnosis, their mortality rates are 40% higher than those observed in white women.  

Authors of the new study stated that their findings are “reassuring” for both clinicians and patients.

This study is one of the largest to date to assess brain growth in opioid-exposed fetuses in utero. 

Also, up to 26% of eligible women have not had a formal conversation with their physician regarding their breast cancer risks, despite current guidelines that suggest these discussions start sooner rather than later.

The boon comes in the form of greater brain cortical thickness observable on neonatal MRI two weeks after the baby enters the world.

Researchers found that cancer risk in premenopausal women with fatty breasts at initial imaging nearly doubled if an increase in density was observed during their second and third mammograms.

The FDA has given its thumbs-up to software that calculates breast fibroglandular tissue volume (FGV) and the ratio of FGV to total breast volume on ultrasound imaging.